Cargando…
Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916294/ https://www.ncbi.nlm.nih.gov/pubmed/27176796 http://dx.doi.org/10.1038/bcj.2016.25 |
| _version_ | 1782438806123708416 |
|---|---|
| author | Perini, G F Campregher, P V Ross, J S Ali, S Hamerschlak, N Santos, F P S |
| author_facet | Perini, G F Campregher, P V Ross, J S Ali, S Hamerschlak, N Santos, F P S |
| author_sort | Perini, G F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4916294 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-49162942016-06-30 Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation Perini, G F Campregher, P V Ross, J S Ali, S Hamerschlak, N Santos, F P S Blood Cancer J Letter to the Editor Nature Publishing Group 2016-05 2016-05-13 /pmc/articles/PMC4916294/ /pubmed/27176796 http://dx.doi.org/10.1038/bcj.2016.25 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Letter to the Editor Perini, G F Campregher, P V Ross, J S Ali, S Hamerschlak, N Santos, F P S Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title | Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title_full | Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title_fullStr | Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title_full_unstemmed | Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title_short | Clinical response to everolimus in a patient with Hodgkin's lymphoma harboring a TSC2 mutation |
| title_sort | clinical response to everolimus in a patient with hodgkin's lymphoma harboring a tsc2 mutation |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916294/ https://www.ncbi.nlm.nih.gov/pubmed/27176796 http://dx.doi.org/10.1038/bcj.2016.25 |
| work_keys_str_mv | AT perinigf clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation AT campregherpv clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation AT rossjs clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation AT alis clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation AT hamerschlakn clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation AT santosfps clinicalresponsetoeverolimusinapatientwithhodgkinslymphomaharboringatsc2mutation |